10-K Decoder · All companies

Castle Biosciences, Inc.

CSTL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$344M$332M+3.7%
Operating income−$42.8M$8.67M
Net income−$24.2M$18.2M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$103M$83.0M+24.0%
Operating income−$2.70M−$6.80M+60.3%
Net income−$4.10M−$500K−720%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Castle Biosciences's revenue in FY2025?
$344M in FY2025 (Fiscal year ended Dec 31, 2025), +3.7% vs $332M a year earlier, per its 10-K filed Feb 2026.
Was Castle Biosciences profitable in FY2025?
No: net income was −$24.2M and operating income −$42.8M in FY2025.
What was Castle Biosciences's revenue in Q3 2026?
$103M (+24.0% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.